|
Synonyms: ACR-2316 | compound 109 [WO2024254490]
Compound class:
Synthetic organic
Comment: Sirusertib is the INN for a serine/threonine kinase inhibitor, that was included in WHO INN Proposed List 135 (July 2026). The chemical structure matches one of those claimed as WEE1/PKMYT1 dual inhibitors in Acrivon Therapeutics' patent WO2024254490A1 [1]. It is likely that sirusertib is the proposed INN for Acrivon's clinical candidate ACR-2316.
Sirusertib is proposed to disrupt WEE1 and PKMYT1-regulated cell cycle checkpoints in cancer cells that are sensitised by existing defective G1/S checkpoint control, thus leading to cell death. Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
Download 2D Structure ![]() |
|
| Canonical SMILES | Download |
| Isomeric SMILES | Download |
| InChI standard identifier | Download |
| InChI standard key | Download |
Molecular structure representations generated using Open Babel